These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9855563)

  • 21. Guideline may help in prescribing vigabatrin.
    Appleton RE
    BMJ; 1998 Nov; 317(7168):1322. PubMed ID: 9804738
    [No Abstract]   [Full Text] [Related]  

  • 22. Study is needed of visual field defects associated with any long term antiepileptic drug.
    Rao GP; Fat FA; Kyle G; Leach JP; Chadwick DW; Batterbury M
    BMJ; 1998 Jul; 317(7152):206. PubMed ID: 9665915
    [No Abstract]   [Full Text] [Related]  

  • 23. [Visual field defects due to antiepileptic drugs].
    Stefan H; Bernatik J; Knorr J
    Nervenarzt; 1999 Jun; 70(6):552-5. PubMed ID: 10412701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
    Mrugacz M; Bakunowicz-Łazarczyk A
    Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe visual-field constriction and side-effects of GABA-mimetic antiepileptic agents.
    Baulac M; Nordmann JP; Lanoé Y
    Lancet; 1998 Aug; 352(9127):546. PubMed ID: 9716066
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversibility of vigabratin-induced visual-field defect.
    Versino M; Veggiotti P
    Lancet; 1999 Aug; 354(9177):486. PubMed ID: 10465180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epilepsy and Sabril].
    Depasse F
    Bull Soc Belge Ophtalmol; 2007; (304):33-40. PubMed ID: 17718226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vigabatrin and visual fields defects].
    Jensen K
    Ugeskr Laeger; 2001 Jan; 163(2):184. PubMed ID: 11379251
    [No Abstract]   [Full Text] [Related]  

  • 29. Outer retinal dysfunction in patients treated with vigabatrin.
    Arndt CF; Derambure P; Defoort-Dhellemmes S; Hache JC
    Neurology; 1999 Apr; 52(6):1201-5. PubMed ID: 10214744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of the retinal nerve fibre layer and reduced retinal function assessed by optical coherence tomography and full-field electroretinography in patients exposed to vigabatrin medication.
    Kjellström U; Andréasson S; Ponjavic V
    Acta Ophthalmol; 2014 Mar; 92(2):149-57. PubMed ID: 23387307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are vigabatrin-associated visual field constrictions asymptomatic?
    Schmidt T; Rüther K; Schmitz B
    J Neurol; 2004 Jul; 251(7):887-8. PubMed ID: 15258797
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy.
    Clayton LM; Duncan JS; Sisodiya SM; Acheson JF
    Eye (Lond); 2010 Jan; 24(1):185-6. PubMed ID: 19373265
    [No Abstract]   [Full Text] [Related]  

  • 33. [Constriction of the visual field by vigabatrin].
    Asensio Sánchez VM
    An Med Interna; 2002 Dec; 19(12):655-6. PubMed ID: 12593042
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures.
    Sergott RC; Johnson CA; Laxer KD; Wechsler RT; Cherny K; Whittle J; Feng G; Lee D; Isojarvi J
    Epilepsia; 2016 Oct; 57(10):1634-1642. PubMed ID: 27580566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vigabatrin-associated visual field loss.
    Fecarotta C; Sergott RC
    Int Ophthalmol Clin; 2012; 52(3):87-94, xii. PubMed ID: 22668542
    [No Abstract]   [Full Text] [Related]  

  • 36. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concentric changes in the visual field associated with GABA-mimetic antiepileptic agents].
    Nordmann JP; Baulac M; Van Egroo C
    J Fr Ophtalmol; 1999 May; 22(4):418-22. PubMed ID: 10365327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings.
    Miller NR; Johnson MA; Paul SR; Girkin CA; Perry JD; Endres M; Krauss GL
    Neurology; 1999 Dec; 53(9):2082-7. PubMed ID: 10599785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of vigabatrin treatment causing visual field defects in infantile spasms.
    Chiron C; Dulac O
    Dev Med Child Neurol; 2015 Jan; 57(1):9-10. PubMed ID: 25109842
    [No Abstract]   [Full Text] [Related]  

  • 40. Visual field defect associated with vigabatrin. Method of estimating prevalence was inappropriate.
    Manuchehri K
    BMJ; 2000 May; 320(7246):1403-4; author reply 1404. PubMed ID: 10858055
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.